Denali Therapeutics Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Denali Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Denali Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was -32.9 %, a 185% decline year-over-year.
  • Denali Therapeutics Inc. annual Return On Equity for 2023 was -13.5 %, a 62.1% increase from 2022.
  • Denali Therapeutics Inc. annual Return On Equity for 2022 was -35.7 %, a 27.4% decline from 2021.
  • Denali Therapeutics Inc. annual Return On Equity for 2021 was -28 %, a 403% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -13.5 +22.2 +62.1% Jan 1, 2023 Dec 31, 2023
2022 -35.7 -7.68 -27.4% Jan 1, 2022 Dec 31, 2022
2021 -28 -37.2 -403% Jan 1, 2021 Dec 31, 2021
2020 9.24 +52.6 Jan 1, 2020 Dec 31, 2020
2019 -43.3 -36.2 -509% Jan 1, 2019 Dec 31, 2019
2018 -7.12 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.